With advisory board approval, the Department of Health would include Gaucher disease in the program's newborn screening and follow-up list.
The text lists Gaucher disease for newborn screening and follow-up. The Department of Health would need approval from the program's advisory board.
The program would provide screening tests and follow-up services for Gaucher disease. The program covers screening tests and follow-up services for newborn children. The Department of Health would establish the program with approval from the Newborn Screening and Follow-up Technical Advisory Board. The act would take effect 60 days after enactment.
No hearings or votes scheduled.